@article{a1ddebe1b20f476babe119df9b2736f2,
title = "Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis",
abstract = "Aim The growing use of immune checkpoint inhibitors (ICIs) is associated with the occurrence of immune-related adverse events (irAEs). Few data are published on systemic, immunohaematological and rheumatic irAEs. In a pharmacovigilance database analysis, we screened for these irAEs and calculated their prevalence.",
keywords = "Connective tissue diseases, Immune thrombocytopenia, Immunotherapy, Rheumatic diseases",
author = "{Le Burel}, S{\'e}bastien and St{\'e}phane Champiat and Christine Mateus and Aur{\'e}lien Marabelle and Michot, {Jean Marie} and Caroline Robert and Rakiba Belkhir and Soria, {Jean Charles} and Salim Laghouati and Voisin, {Anne Laure} and Olivier Fain and Ars{\`e}ne M{\'e}kinian and Laetitia Coutte and Szwebel, {Tali Anne} and Laetitia Dunogeant and Bertrand Lioger and C{\'e}cile Luxembourger and Xavier Mariette and Olivier Lambotte",
note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Ltd",
year = "2017",
month = sep,
day = "1",
doi = "10.1016/j.ejca.2017.05.032",
language = "English",
volume = "82",
pages = "34--44",
journal = "European Journal of Cancer",
issn = "0959-8049",
}